Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection, 6 gm/30 mL ...
Glenmark Pharmaceuticals Inc. USA has acquired and launched Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose ...
Glenmark’s Acetylcysteine Injection (DEL) is approved based on the safety and efficacy derived from the reference drug ...
This new product will be available in the strength of 6 gm/30 mL (200 mg/mL) single-dose vials in the US market, marking an ...
Glenmark Pharmaceuticals has launched injection Acetylcysteine in the US after acquiring its abbreviated new drug application ...
Glenmark Pharmaceuticals has acquired generic Acetylcysteine injection for acetaminophen overdose treatment and launched it ...
(RTTNews) - Glenmark Pharmaceuticals Inc., USA announces the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL Single-Dose Vials. The company acquired the ANDA for Acetylcysteine ...
Glenmark Pharma acquires and launches acetylcysteine injection, 6 gm/30 mL (200 mg/mL) single-dose vials: Our Bureau, Mumbai Monday, March 3, 2025, 12:15 Hrs [IST] Glenmark Pharma ...
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials. Glenmark's Acetylcysteine Injection, 6 gm/30 ...
Glenmark Pharmaceuticals Inc., USA announced today the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials in the US market. The shares of Glenmark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback